SYRE
Spyre Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Spyre Therapeutics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
6 direct
−0.23%
vs ±11.9% implied · ×0.02
shaded = implied · ▲▼ = realized
Spyre Therapeutics, Inc.
95.84
−3.20 · −3.23%
Expected move
Inputsspot 99.04exp Mar 19ATM strike 100ATM straddle 30.10IV 63%